- Home
- AEG vs BMRN Comparison
AEG vs BMRN Comparison
Compare AEG & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEG
- BMRN
- Stock Information
- Founded
- AEG 1983
- BMRN 1996
- Country
- AEG Netherlands
- BMRN United States
- Employees
- AEG N/A
- BMRN N/A
- Industry
- AEG Life Insurance
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AEG Finance
- BMRN Health Care
- Exchange
- AEG Nasdaq
- BMRN Nasdaq
- Market Cap
- AEG 12.0B
- BMRN 9.9B
- IPO Year
- AEG N/A
- BMRN 1999
- Fundamental
- Price
- AEG $7.91
- BMRN $54.34
- Analyst Decision
- AEG
- BMRN Buy
- Analyst Count
- AEG 0
- BMRN 19
- Target Price
- AEG N/A
- BMRN $90.26
- AVG Volume (30 Days)
- AEG 4.9M
- BMRN 2.8M
- Earning Date
- AEG 01-01-0001
- BMRN 10-27-2025
- Dividend Yield
- AEG 4.76%
- BMRN N/A
- EPS Growth
- AEG N/A
- BMRN 59.53
- EPS
- AEG 0.93
- BMRN 2.68
- Revenue
- AEG $15,344,685,849.00
- BMRN $3,094,001,000.00
- Revenue This Year
- AEG N/A
- BMRN $13.32
- Revenue Next Year
- AEG $2.04
- BMRN $7.51
- P/E Ratio
- AEG $8.43
- BMRN $20.23
- Revenue Growth
- AEG 2.83
- BMRN 12.39
- 52 Week Low
- AEG $5.42
- BMRN $50.76
- 52 Week High
- AEG $8.15
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- AEG 66.21
- BMRN 53.26
- Support Level
- AEG $7.50
- BMRN $50.76
- Resistance Level
- AEG $7.64
- BMRN $53.49
- Average True Range (ATR)
- AEG 0.08
- BMRN 1.89
- MACD
- AEG 0.05
- BMRN 0.30
- Stochastic Oscillator
- AEG 83.74
- BMRN 57.78
About AEG Aegon Ltd. New York Registry Shares
Aegon is a life insurance and long-term savings business listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the group that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.